AVADEL PHARMACEUTICALS (AVDL)

IE00BDGMC594 - Common Stock

18.82  +0.52 (+2.84%)

After market: 18.82 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
27.96M0.000.0022.30M59.20M
Cost Of Goods
846.00KN/A0.005.70M12.10M
Gross Profit
27.12MN/A0.0016.60M47.10M
Operating Expenses
164.97M95.30M85.60M56.60M64.80M
Research and Development
13.26M20.70M17.10M20.40M32.90M
Selling, General, and Administrative Expenses
151.71M74.50M68.50M32.40M30.20M
Operating Income
-137.85M-95.30M-85.60M-40.00M-17.70M
Interest Income/Expense
-9.89M-12.30M-9.90M-13.00M-12.50M
Other Income/Expense
87.00K-500.00K2.30M2.10M700.00K
Non Recurring Items
-13.13M-3.30M100.00K45.80M-9.10M
Income Before Taxes
-160.78M-111.40M-93.10M-5.10M-38.60M
Income Tax
-501.00K26.00M-15.80M-3.00M-5.40M
Net Income
-160.28M-137.50M-77.30M7.00M-33.20M
EBITDA
-136.08M-93.81M-84.78M-38.31M-15.21M
 
Per Share Data
EPS Diluted Total Ops
-1.98-2.27-1.310.12-0.88
Non GAAP EPS
-2.01-2.25-1.32-0.56-0.89
 
Statistics
Gross Profit Margin
96.97%N/AN/A74.44%79.56%
Profit Margin
-573.17%N/AN/A31.39%-56.08%
Operating Profit Margin
-492.97%N/AN/A-179.37%-29.90%

All data in USD

Charts